Kaneka Probiotics is a supplier and pioneer of single strains and blends of precision probiotics and postbiotics, designed for targeted, validated health outcomes. Rather than offering commodity, one-size-fits-all formulas, Kaneka develops strain-specific solutions built around a deep understanding of our "Microbial Old Friends," probiotic strains isolated from populations with strong health outcomes and minimal modern lifestyle exposure.
With a strain library of 500+ strains, 200+ patents, and 50+ clinical trials across 80+ markets, Kaneka combines 20 years of science, regulatory expertise, and formulation capability to help partners bring clinically backed products to market. Our portfolio addresses gut, immune, mood, women's health, infant, metabolic, skin, athletic performance, weight, and oral health, available across formats from capsules and gummies to sticks, shots, and topicals.
Beyond ingredient development, Kaneka offers the technical capabilities and market insight to support formulators and brand managers from concept through commercialization, and we continue investing in clinical research to substantiate how our finished commercial products actually perform.
